76 related articles for article (PubMed ID: 8295819)
1. The 5q35bp chromosomal abnormality characterizes certain CD30 positive anaplastic large cell lymphomas offering a new definition of malignant histiocytosis in childhood.
Nezelof C
Nouv Rev Fr Hematol (1978); 1993; 35(5):463-7. PubMed ID: 8295819
[TBL] [Abstract][Full Text] [Related]
2. [Toward a new definition of malignant histiocytosis in children].
Nezelof C
Bull Mem Acad R Med Belg; 1992; 147(11-12):472-8; discussion 478-80. PubMed ID: 1341571
[TBL] [Abstract][Full Text] [Related]
3. Malignant histiocytosis in childhood: a distinctive CD30-positive clinicopathological entity associated with a chromosomal translocation involving 5q35.
Nezelof C; Barbey S; Gogusev J; Terrier-Lacombe MJ
Semin Diagn Pathol; 1992 Feb; 9(1):75-89. PubMed ID: 1313990
[TBL] [Abstract][Full Text] [Related]
4. Malignant histiocytosis. Histologic, cytochemical, chromosomal, and molecular data with a nosologic discussion.
Gogusev J; Nezelof C
Hematol Oncol Clin North Am; 1998 Apr; 12(2):445-63. PubMed ID: 9561912
[TBL] [Abstract][Full Text] [Related]
5. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
6. Genotype markers and proto-oncogene analysis in the CD30-positive "malignant histiocytosis" DEL cell line with t(5;6)(q35;p21).
Gogusev J; Barbey S; Nezelof C
Int J Cancer; 1990 Jul; 46(1):106-12. PubMed ID: 2163988
[TBL] [Abstract][Full Text] [Related]
7. Malignant histiocytosis. A phenotypic and genotypic investigation.
Cattoretti G; Villa A; Vezzoni P; Giardini R; Lombardi L; Rilke F
Am J Pathol; 1990 May; 136(5):1009-19. PubMed ID: 2349962
[TBL] [Abstract][Full Text] [Related]
8. Human malignant histiocytosis CD30+ DEL cell line differentiates into macrophage-like cells when treated with a phorbol diester.
Gogusev J; Barbey S; Nezelof C
Cancer Res; 1991 Oct; 51(20):5712-5. PubMed ID: 1913689
[TBL] [Abstract][Full Text] [Related]
9. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
10. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
Hsu FY; Johnston PB; Burke KA; Zhao Y
Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
[TBL] [Abstract][Full Text] [Related]
11. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis.
Morgan R; Smith SD; Hecht BK; Christy V; Mellentin JD; Warnke R; Cleary ML
Blood; 1989 Jun; 73(8):2155-64. PubMed ID: 2525056
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.
Nishikori M; Ohno H; Haga H; Uchiyama T
Cancer Sci; 2005 Aug; 96(8):487-97. PubMed ID: 16108830
[TBL] [Abstract][Full Text] [Related]
13. Regulation of TNF-alpha and IL-1 gene expression during TPA-induced differentiation of "Malignant histiocytosis" DEL cell line t(5;6) (q35:p21).
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1996; 16(1):455-60. PubMed ID: 8615653
[TBL] [Abstract][Full Text] [Related]
14. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
15. Specific patterns of chromosomal gains and losses associate with t(3;14), t(8;14), and t(14;18) in diffuse large B-cell lymphoma.
Sheth A; de Melo VA; Szydlo R; Macdonald DH; Reid AG; Wagner SD
Cancer Genet Cytogenet; 2009 Oct; 194(1):48-52. PubMed ID: 19737654
[TBL] [Abstract][Full Text] [Related]
16. New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17).
Hu ZB; Quentmeier H; Meyer C; Kaufmann M; MacLeod RA; Drexler HG
Leuk Res; 2004 May; 28(5):509-15. PubMed ID: 15068904
[TBL] [Abstract][Full Text] [Related]
17. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
18. Microvillous lymphomas are B-cell neoplasms that frequently express CD56.
Hammer RD; Vnencak-Jones CL; Manning SS; Glick AD; Kinney MC
Mod Pathol; 1998 Mar; 11(3):239-46. PubMed ID: 9521469
[TBL] [Abstract][Full Text] [Related]
19. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
Fang JM; Finn WG; Hussong JW; Goolsby CL; Cubbon AR; Variakojis D
Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.
Delsol G; Al Saati T; Gatter KC; Gerdes J; Schwarting R; Caveriviere P; Rigal-Huguet F; Robert A; Stein H; Mason DY
Am J Pathol; 1988 Jan; 130(1):59-70. PubMed ID: 2827494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
